Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 33.3%Moderate 2 · 66.7%High 0 · 0%

Progression‐free survival · patients with epithelial ovarian cancer

Maintenance chemotherapy showed no clear difference in 3‐year PFS compared with maintenance radiotherapy (low certainty).

1 finding from 1 review

Maintenance chemotherapy for ovarian cancer 2013 · Cochrane Headline outcomes only
RR 1.07 [0.75, 1.54]
1 study · 141 participants
Low

Progression‐free survival · patients with epithelial ovarian cancer

Maintenance chemotherapy showed no clear difference in 3‐year PFS compared with observation (moderate certainty).

1 finding from 1 review

Maintenance chemotherapy for ovarian cancer 2013 · Cochrane Headline outcomes only
RR 1.07 [0.91, 1.25]
4 studies · 541 participants
Moderate

Progression‐free survival · patients with epithelial ovarian cancer

Platin‐based maintenance chemotherapy showed no clear difference in 3‐year PFS compared with observation (moderate certainty).

1 finding from 1 review

Maintenance chemotherapy for ovarian cancer 2013 · Cochrane Headline outcomes only
RR 1.04 [0.86, 1.24]
3 studies · 341 participants
Moderate